Ron Laufer insider trades: Catabasis Pharmaceuticals (CATB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ron reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 30, 2015 | CATB | ↑ Buy | 223,439 | $12.00 | $2.7M | Indirect | Jun 30, 2015 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ron Laufer's insider trades
Ron Laufer is a director at Catabasis Pharmaceuticals (CATB). Since Jun 30, 2015, Ron has reported 1 open-market purchase worth $2.7M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include conversions (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CATB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.